Search
forResearch 10 of 221
- Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
- Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
- The Association between COVID-19 Infection and Gabrin Sign: A Case-Control Study
- Reply to comment on: The Gabrin sign
- The Gabrin sign's potential for identifying high‐risk patients for COVID‐19 with androgenic alopecia
- Comment on: The Gabrin sign
- Literature ReviewThe Gabrin Sign and Role of Androgens in COVID-19 Severity: A Look at 3 Studies
- Evaluating the Role of the Gabrin Sign in Predicting COVID-19 Severity Among Patients with Androgenic Alopecia
- Faculty Opinions recommendation of Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients – the “Gabrin sign”.
- Raw data from JAAD research letter: Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →